EcoR1 Capital as of Sept. 30, 2023
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 49 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prothena Corp SHS (PRTA) | 18.9 | $559M | 12M | 48.25 | |
| Apellis Pharmaceuticals (APLS) | 14.9 | $443M | 12M | 38.04 | |
| Mirati Therapeutics | 8.4 | $250M | 5.7M | 43.56 | |
| Galapagos Nv Spon Adr (GLPG) | 6.7 | $199M | 5.8M | 34.55 | |
| Revolution Medicines (RVMD) | 5.2 | $155M | 5.6M | 27.68 | |
| Anaptysbio Inc Common (ANAB) | 4.6 | $135M | 7.5M | 17.96 | |
| ACADIA Pharmaceuticals (ACAD) | 4.2 | $125M | 6.0M | 20.84 | |
| Arvinas Ord (ARVN) | 3.6 | $107M | 5.5M | 19.64 | |
| Xencor (XNCR) | 3.6 | $106M | 5.3M | 20.15 | |
| Tango Therapeutics (TNGX) | 3.3 | $98M | 8.7M | 11.26 | |
| Zymeworks Del (ZYME) | 2.9 | $85M | 13M | 6.34 | |
| Springworks Therapeutics (SWTX) | 2.7 | $80M | 3.5M | 23.12 | |
| Kura Oncology (KURA) | 1.8 | $53M | 5.8M | 9.12 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.6 | $48M | 368k | 129.44 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.5 | $46M | 1.5M | 29.74 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.2 | $36M | 5.6M | 6.47 | |
| Relay Therapeutics (RLAY) | 1.2 | $35M | 4.2M | 8.41 | |
| Morphic Hldg (MORF) | 1.1 | $34M | 1.5M | 22.91 | |
| Voyager Therapeutics (VYGR) | 1.0 | $30M | 3.9M | 7.75 | |
| Neumora Therapeutics Com Added (NMRA) | 1.0 | $29M | 2.1M | 14.11 | |
| Alector (ALEC) | 0.9 | $26M | 4.1M | 6.48 | |
| Nuvation Bio Com Cl A (NUVB) | 0.9 | $26M | 19M | 1.34 | |
| Mersana Therapeutics | 0.8 | $25M | 19M | 1.27 | |
| Ovid Therapeutics (OVID) | 0.8 | $24M | 6.1M | 3.84 | |
| Graphite Bio | 0.7 | $21M | 8.5M | 2.48 | |
| Atea Pharmaceuticals (AVIR) | 0.7 | $21M | 7.0M | 3.00 | |
| Oric Pharmaceuticals (ORIC) | 0.7 | $21M | 3.4M | 6.05 | |
| Edgewise Therapeutics (EWTX) | 0.7 | $20M | 3.5M | 5.73 | |
| Third Harmonic Bio (THRD) | 0.6 | $19M | 3.0M | 6.39 | |
| Acelyrin | 0.5 | $14M | 1.4M | 10.17 | |
| Allogene Therapeutics (ALLO) | 0.5 | $14M | 4.5M | 3.17 | |
| Tscan Therapeutics (TCRX) | 0.4 | $13M | 5.0M | 2.56 | |
| Deciphera Pharmaceuticals | 0.4 | $13M | 993k | 12.72 | |
| Generation Bio | 0.3 | $7.8M | 2.0M | 3.79 | |
| Gossamer Bio (GOSS) | 0.3 | $7.7M | 9.2M | 0.83 | |
| Phathom Pharmaceuticals (PHAT) | 0.2 | $7.3M | 700k | 10.37 | |
| Ngm Biopharmaceuticals | 0.2 | $6.9M | 6.4M | 1.07 | |
| Prime Medicine (PRME) | 0.2 | $5.7M | 600k | 9.54 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.1 | $3.9M | 3.0M | 1.30 | |
| Prelude Therapeutics (PRLD) | 0.1 | $3.6M | 1.2M | 3.09 | |
| Aligos Therapeutics | 0.1 | $2.9M | 3.9M | 0.75 | |
| Hookipa Pharma Inc equity | 0.1 | $2.8M | 4.6M | 0.62 | |
| Aeglea Biotherapeutics Com New Added (SYRE) | 0.1 | $2.4M | 200k | 12.25 | |
| Allakos | 0.1 | $1.7M | 749k | 2.27 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $1.3M | 963k | 1.34 | |
| Newamsterdam Pharma Company *w Exp 11/22/202 (NAMSW) | 0.0 | $617k | 67k | 9.25 | |
| Tempest Therapeutics | 0.0 | $284k | 931k | 0.30 | |
| Caremax *w Exp 06/08/202 | 0.0 | $212k | 100k | 2.12 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $33k | 67k | 0.49 |
